Free Trial

Finch Therapeutics Group (FNCH) SEC Filings & 10K Form

Finch Therapeutics Group logo
$12.00 +0.75 (+6.67%)
(As of 11/14/2024 ET)

Recent Finch Therapeutics Group SEC Filings

DateFilerForm TypeView
11/04/2024
11:15 PM
Finch Therapeutics Group (Filer)
Form EFFECT
11/01/2024
7:01 AM
Finch Therapeutics Group (Filer)
Form S-8 POS
11/01/2024
7:02 AM
Finch Therapeutics Group (Filer)
Form S-8 POS
11/01/2024
7:02 AM
Finch Therapeutics Group (Filer)
Form S-8 POS
11/01/2024
7:02 AM
Finch Therapeutics Group (Filer)
Form POS AM
10/31/2024
7:00 AM
Finch Therapeutics Group (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
10/21/2024
6:45 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:16 PM
Finch Therapeutics Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:30 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
6:00 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
7:00 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:05 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
3:45 PM
Finch Therapeutics Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:57 PM
Finch Therapeutics Group (Filer)
Form 10-K/A
04/03/2024
6:30 AM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:15 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Finch Therapeutics Group (Subject)
SMISEK JEFFERY A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
4:20 PM
Finch Therapeutics Group (Subject)
Ugwumba Chidozie (Filed by)
Form SC 13G
11/27/2023
3:54 PM
Finch Therapeutics Group (Issuer)
SMISEK JEFFERY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:37 PM
Finch Therapeutics Group (Subject)
SMISEK JEFFERY A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:30 PM
Finch Therapeutics Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FNCH) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners